![SymBio Pharmaceuticals Limited logo](/logos/4582.T.webp)
SymBio Pharmaceuticals Limited
TSE:4582.T
Overview | Financials
Company Name | SymBio Pharmaceuticals Limited |
Symbol | 4582.T |
Currency | JPY |
Price | 249 |
Market Cap | 11,409,333,384 |
Dividend Yield | 0% |
52-week-range | 146 - 475 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Fuminori Yoshida |
Website | https://www.symbiopharma.com |
An error occurred while fetching data.
About SymBio Pharmaceuticals Limited
SymBio Pharmaceuticals Limited engages in the research and development, manufacturing, and marketing of pharmaceutical drugs in the areas of oncology and hematology in Japan. It is involved in the development of Treakisym SyB L-0501, an anti-cancer agent, which is marketed for the treatment of non-Hodgkin's lymphoma, multiple myeloma, and chronic
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD